Invest in life-saving innovation
Discover Vivantis
We are a healthcare innovation company developing a smart drug–device–digital platform that transforms complex therapies into safe, personalized care. Your investment powers the next generation of treatment.
Our purpose
Turning uncertain dosing into life-saving precision
Marie is a 66-year-old woman living with a heart condition that requires daily medication. Despite following her doctor’s instructions, the standard pills she takes are unpredictable — sometimes too weak, sometimes too strong — putting her at constant risk of complications and repeated hospital visits.
Our mission is to change that. With our precision drug-device-digital platform, every dose Marie takes is tailored to her needs, monitored in real-time, and kept safe. She can finally trust her therapy, stay out of the hospital, and live her life fully.
Your investment helps us make this future possible for Marie — and for millions of patients worldwide who deserve safer, more reliable treatments.
Picture for illustration
We are building the Future of safe dosing.
As a tech-enabled company, we are developing fully integrated Drug–Device–Digital therapies that solve a major flaw in modern medicine: imprecise dosing for patients with high-risk conditions.
This end-to-end system enables truly personalized care, with AI-driven insights and remote monitoring — saving lives, reducing costs, and creating commercial value.
The Warfarin case
This snapshot of the Warfarin use case shows how our smart system can dramatically reduce dangerous complications like major bleeds and strokes — saving both lives and healthcare costs. Among the 294,000 eligible patients in the U.S., a 10% reduction in the 4% annual major event rate means preventing around 1,176 serious complications each year, including approximately 882 major bleeds and 294 strokes — leading to about 1,176 avoidable hospitalizations. At 30% reduction, that’s over 3,500 prevented complications annually. Financially, a 10% reduction saves payers $190 per patient per year — an estimated $55 million in total annual savings. A 30% reduction triples both the health and economic impact.
Disclaimer: These figures are provisional estimates, not confirmed by clinical trial data. They are intended for illustrative purposes and may vary once validated through clinical studies.
Real-world examples
Genetic hyper‑responsiveness in a 22-year-old
Severe bleeding from overdosing in a 74-year-old
Human error in hospital leading to dangerous INR spike
Source: Assem, M., Gaba, A., et al. (2022). Rare CYP2C9146 and VKORC1-1639GA alleles result in overanticoagulation in a young patient on warfarin therapy: A case report. Thrombosis Journal, 20(1), 33.
Source: Shahin, M. H., Khalifa, S. I., El-Sherbeni, A. A., et al. (2014). Warfarin Pharmacogenetics: A Case Report of Genetic Sensitivity and a Review of the Literature. Case Reports in Medicine, 2014, Article ID 413743.
Source : Roy, C. L., Poon, E. G., et al. (2004). Patient safety in anticoagulation management: a case report and review.Journal of Hospital Medicine, PMC4057544.
Why your investment matters?
Every dollar invested helps accelerate our journey from innovation to global deployment — moving faster from prototype to clinical trials, regulatory approval, and worldwide access.
By supporting us today, you contribute directly to safer therapies and fewer hospitalizations for high-risk patients.
-
Accelerated milestones
-
Lives saved through smarter dosing
-
A seat at the table as we transform patient care
Join a growing movement where purpose meets potential.
Why this matters for you as an investor?
You are not just backing an idea — you are investing in a mission-driven company with the technical expertise, industry network, and execution track record to bring a life-saving innovation from concept to global adoption.
Words from our CEO
"In healthcare, success is not just about having a good idea — it is about having the experience to make it real. We have both."
Contact Us
We welcome interest from potential investors in our mission to transform precision medicine.
Please contact us if you would like to learn more about upcoming opportunities to support our company.
Disclaimer: This website is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Investment opportunities will only be made available through proper legal channels and in compliance with applicable securities laws.